Timothy Romberger

Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA.

Trinsum Group, Inc. provides management consulting services. It provides services in the areas of strategy, execution, organic growth, growth through acquisition, productivity and risk management. The company was founded by James M. McTaggart in 1978 and is headquartered in New York, NY.

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Sur-Seal LLC develops, manufactures, and sells engineered sealing solutions and components for original equipment manufactures (OEMs). The firm offers rubber, plastic, graphite, silicone optics, medical tubing, and light diffusing and reflecting materials. The company was founded in 1965 and is headquartered in Cincinnati, OH.